Premenstrual and menstrual symptomatology in young adult Japanese females who smoke tobacco

Journal of Obstetrics and Gynaecology Research

Volumn 37, Issue 4, 2011, Pages 325-330

  Sakai, Hiroko ^a   Kawamura, Chieko ^b   Cardenas, Xiaodong ^b   Ohashi, Kazutomo ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Sonoda Women's University   (Japan)

Author keywords

Nicotine dependency; Premenstrual symptomatology; Smoking; Smoking motives; Young adult female

Indexed keywords

ADULT; AROUSAL; ARTICLE; AUTONOMIC NEUROPATHY; BEHAVIOR CHANGE; CIGARETTE SMOKING; CONCENTRATION LOSS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE SEVERITY; EMOTIONAL DISORDER; FAGERSTROM TEST FOR NICOTINE DEPENDENCE; FEMALE; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MENOPAUSAL SYNDROME; MENSTRUAL CYCLE; MOOS MENSTRUAL DISTRESS QUESTIONNAIRE; PAIN; PREMENSTRUAL SYNDROME; QUESTIONNAIRE; RATING SCALE; REASONS FOR SMOKING SCALE; TOBACCO DEPENDENCE; WATER RETENTION;

ADOLESCENT; ADULT; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; JAPAN; MENSTRUATION DISTURBANCES; PREMENSTRUAL SYNDROME; SMOKING; TOBACCO USE DISORDER; YOUNG ADULT;

EID: 79956062734     PISSN: 13418076     EISSN: 14470756     Source Type: Journal    
DOI: 10.1111/j.1447-0756.2010.01353.x     Document Type: Article

References (26)

1. World Health Organization. WHO report on the global tobacco epidemic 2008-The MPOWER package. [Cited 4 October 2010.] Available from URL: http://www.who.int/tobacco/mpower-report-full-2008.pdf
2. Bohadana A, Nilsson F, Rasmussen T, Martinet Y. Gender differences in quit rates following smoking cessation with combination nicotine therapy: influence of base line smoking behavior. Nicotine Tob Res 2003; 5: 111-116.
3. Collins BN, Wileyto EP, Patterson F et al. Gender differences in smoking cessation in a placebo-controlled trial of bupro-pion with behavioral counseling. Nicotine Tob Res 2004; 6: 27-37. (Pubitemid 38372471)
4. Carpenter MJ, Upadhyaya HP, LaRowe SD, Saladin ME, Brady KT. Menstrual cycle phase effects on nicotine with-drawal and cigarette craving: a review. Nicotine Tob Res 2006; 8: 627-638. (Pubitemid 44480412)
5. DeBon M, Klesges RC, Klesges LM. Symptomatology across the menstrual cycle in smoking and nonsmoking women. Addict Behav 1995; 20: 335-343.
6. Allen SS, Allen AM, Pomeruleau CS. Influence of phase-related variability in premenstrual symptomatology mood, smoking withdrawal, and smoking behavior during ad libitum smoking, on smoking cessation outcome. Addict Behav 2009; 34: 107-111.
7. Bertone-Johnson ER, Hankinson SE, Johnson AR, Manson JE. Cigarette smoking and the development of premenstrual syndrome. Am J Epidemiol 2008; 168: 938-945.
8. Heatherton TF, Kozlowski LT, Frecker RC, Fagerström KO. The Fagerström test for nicotine dependence: a revision of the Fagerström Tolerance Questionnaire. Br J Addict 1991; 86: 1119-1127.
9. Costa PO, McCrae RR, Bosse R. Smoking motive factors: a review and replication. Int J Addict 1980; 15: 537-549. (Pubitemid 10004528)
10. Moos RH. The development of the menstrual distress ques-tionnaire. Psychosom Med 1968; 30: 853-867.
11. Tomkins S. A psychological model of smoking behavior. Am J Public Health 1966; 56 (Suppl): 17-20.
12. Tate JC, Stanton AL. Assessment of the validity of the Reasons for Smoking Scale. Addict Behav 1990; 15: 129-135. (Pubitemid 20155205)
13. Currie SR. Confirmatory factor analysis of the Reasons for Smoking Scale in alcoholics. Nicotine Tob Res 2004; 6: 465-470. (Pubitemid 38967535)
14. Berlin I, Singleton EG, Pedarriosse AM et al. The modified Reasons for Smoking Scale: functional structure, gender effects and relationship with nicotine dependence and smoking cessation in French smokers. Addiction 2003; 98: 1575-1583. (Pubitemid 37373856)
15. De Souza ES, Crippa JA, Pasian SR, Martinez JA. Modified Reasons for Smoking Scale: translation to Portuguese, cross-cultural adaptation for use in Brazil and evaluation of test-retest reliability. J Bras Pneumol 2009; 35: 683-689.
16. Seto M, Takada S, Ogawa K, Ueda I. Development of the Reasons for Smoking Assessment Scale (RSAR) and effects of nicotine dependence on smoking as a coping behavior to stress. Hum Sci Res 1998; 11: 101-108. (In Japanese.)
17. Stotland NL, Berek JS (eds). J.S. Berek and Novak's Gynecology, 14th edn. Philadelphia, PA: Lippincot Wiliams and Wilkins, 2007; 358-360.
18. Wyatt KM, Dimmock PW, O'Brien PMS. Selective serotonin reuptake inhibitors for premenstrual syndrome. Cochrane Database Syst Rev 2002; 3. Art. No.: CD001396. DOI: 10.1002/14651858.CD001396.
19. Lopez LM, Kaptein A, Helmerhorst FM. Oral contraceptives containing drospirenone for premenstrual syndrome. Cochrane Database Syst Rev 2008; 1. Art. No.: CD006586. DOI: 10.1002/14651858.CD006586.pub2. (Pubitemid 351807638)
20. American College of Obstetricians and Gynecologists. Pre-menstrual syndrome. ACOG Prac Bull 2000; 15: 1-9.
21. Franklin TR, Ehrman R, Lynch KG et al. Menstrual cycle phase at quit date predicts smoking status in an NRT treatment trial: a retrospective analysis. J Women's Health 2008; 17: 287-292. (Pubitemid 351631249)
22. Carpenter MJ, Saladin ME, Leinbach AS, Larowe SD, Upadyaya HP. Menstrual phase effects on smoking cessation: a pilot feasibility study. J Women's Health 2008; 17: 293-301. (Pubitemid 351631248)
23. Allen SS, Bade T, Center B, Finstad D, Hatsukami D. Men-strual phase effects on smoking relapse. Addiction 2008; 103: 809-821. (Pubitemid 351537675)
24. Allen SS, Allen AM, Lunos S, Hatsukami DK. Patterns of self-selected smoking cessation attempts and relapse by men-strual phase. Addict Behav 2009; 34: 928-931.
25. Hughes JR, Stead LF, Lancaster T. Antidepressants for smoking cessation. Cochrane Database Syst Reviews 2007; 1. Art. No.: CD000031. DOI: 10.1002/14651858.CD000031.pub3. (Pubitemid 351820390)
26. Haywood A, Slade P, King H. Assessing the assessment mea-sures for menstrual cycle symptoms: a guide for researchers and clinicians. J Psychosom Res 2002; 52: 223-237. (Pubitemid 34477083)